Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelia Vlachou

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Urology|October 22, 2024
The biologic landscape and therapeutic implications of upper tract urothelial cancerEvangelia Vlachou, Jeannie Hoffman-Censits, Nirmish Singla
Clinical Medicine Insights. Oncology|December 17, 2024
The Role of Antibody-Drug Conjugates in Urothelial Cancer: A Review of Recent Advances in the Treatment of Locally Advanced and Metastatic Urothelial CancerEvangelia Vlachou, Burles Avner Johnson, Jean Hoffman-Censits
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 13, 2024
Current Advances in the Management of Nonurothelial Subtypes of Bladder CancerEvangelia Vlachou, Burles Avner Johnson, Ezra Baraban, et al.
Plastic and Reconstructive Surgery|June 27, 2006
Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practiceNaiem S Moiemen, Evangelia Vlachou, Jonathan J Staiano, et al.
The Canadian Journal of Urology|June 24, 2024
Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experienceEvangelia Vlachou, Burles Avner Johnson Ⅲ, Elizabeth Guancial, et al.
Burns : Journal of the International Society for Burn Injuries|October 26, 2007
The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorptionEvangelia Vlachou, Elizabeth Chipp, Elizabeth Shale, et al.
International Journal of Molecular Sciences|November 9, 2024
Neurosteroids Alter p-ERK Levels and Tau Distribution, Restraining the Effects of High Extracellular CalciumVasiliki Konsta, Maria Paschou, Nikoleta Koti, et al.
Clinical Genitourinary Cancer|April 30, 2024
Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab VedotinEvangelia Vlachou, Ronac Mamtani, Noah M Hahn, et al.
Frontiers in Oncology|June 27, 2024
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experienceEvangelia Vlachou, Burles Avner Johnson, David McConkey, et al.
Scientific Reports|April 29, 2025
Tactile contribution extends beyond exteroception during spatially guided finger movementsMaria Evangelia Vlachou, Juliette Legros, Cécile Sellin, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Urology|October 22, 2024
The biologic landscape and therapeutic implications of upper tract urothelial cancerEvangelia Vlachou, Jeannie Hoffman-Censits, Nirmish Singla
Clinical Medicine Insights. Oncology|December 17, 2024
The Role of Antibody-Drug Conjugates in Urothelial Cancer: A Review of Recent Advances in the Treatment of Locally Advanced and Metastatic Urothelial CancerEvangelia Vlachou, Burles Avner Johnson, Jean Hoffman-Censits
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 13, 2024
Current Advances in the Management of Nonurothelial Subtypes of Bladder CancerEvangelia Vlachou, Burles Avner Johnson, Ezra Baraban, et al.
Plastic and Reconstructive Surgery|June 27, 2006
Reconstructive surgery with Integra dermal regeneration template: histologic study, clinical evaluation, and current practiceNaiem S Moiemen, Evangelia Vlachou, Jonathan J Staiano, et al.
The Canadian Journal of Urology|June 24, 2024
Frontline immune checkpoint inhibitors in patients ≥ 90 years with advanced urothelial cancer: a single center experienceEvangelia Vlachou, Burles Avner Johnson Ⅲ, Elizabeth Guancial, et al.
Burns : Journal of the International Society for Burn Injuries|October 26, 2007
The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorptionEvangelia Vlachou, Elizabeth Chipp, Elizabeth Shale, et al.
International Journal of Molecular Sciences|November 9, 2024
Neurosteroids Alter p-ERK Levels and Tau Distribution, Restraining the Effects of High Extracellular CalciumVasiliki Konsta, Maria Paschou, Nikoleta Koti, et al.
Clinical Genitourinary Cancer|April 30, 2024
Racial Differences in Cutaneous Events Among Patients Receiving Enfortumab VedotinEvangelia Vlachou, Ronac Mamtani, Noah M Hahn, et al.
Frontiers in Oncology|June 27, 2024
Enfortumab vedotin-related cutaneous toxicity correlates with overall survival in patients with urothelial cancer: a retrospective experienceEvangelia Vlachou, Burles Avner Johnson, David McConkey, et al.
Scientific Reports|April 29, 2025
Tactile contribution extends beyond exteroception during spatially guided finger movementsMaria Evangelia Vlachou, Juliette Legros, Cécile Sellin, et al.
Pageof 2